HUTCHMED (China) (HCM) Other Non-Current Liabilities (2015 - 2025)
HUTCHMED (China) (HCM) reported Other Non-Current Liabilities of $13.2 million for Q4 2025, up 358.53% year-over-year from $2.9 million in Q4 2024, and down 85.81% quarter-over-quarter from $93.0 million in Q2 2025.
HUTCHMED (China) (HCM) Other Non-Current Liabilities (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Other Non-Current Liabilities data on file, last reported at $13.2 million in Q4 2025.
- Other Non-Current Liabilities for Q4 2025 came in at $13.2 million, up 358.53% year-over-year; the trailing twelve-month figure through Dec 2025 was $13.2 million (up 358.53% YoY), and the FY2025 annual result was $89.3 million, up 2016.78% from the prior year.
- Other Non-Current Liabilities retreated to $13.2 million in Q4 2025 per HCM's latest filing, from $93.0 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $2.8 billion in Q4 2023 and troughed at $2.9 million in Q4 2024.
- A 5-year average of $275.6 million and a median of $13.2 million in 2025 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities surged 88088.42% in 2023, then tumbled 99.9% in 2024.
- A 5-year view of Other Non-Current Liabilities shows it stood at $7.0 million in 2021, then tumbled by 53.73% to $3.2 million in 2022, then jumped by 88088.42% to $2.8 billion in 2023, then sank by 99.9% to $2.9 million in 2024, then soared by 358.53% to $13.2 million in 2025.
- Business Quant data shows HCM's Other Non-Current Liabilities at $13.2 million in Q4 2025, $93.0 million in Q2 2025, and $2.9 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | HUTCHMED (China) | 1.16 Bn | -306.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.21 Mn |
| Jun 30, 2025 | 93.04 Mn |
| Dec 31, 2024 | 2.88 Mn |
| Jun 30, 2024 | 19.31 Mn |
| Dec 31, 2023 | 2.84 Bn |
| Jun 30, 2023 | 19.29 Mn |
| Dec 31, 2022 | 3.22 Mn |
| Jun 30, 2022 | 20.21 Mn |
| Dec 31, 2021 | 6.96 Mn |
| Jun 30, 2021 | 5.52 Mn |
| Mar 31, 2021 | 6.81 Mn |
| Dec 31, 2020 | 8.78 Mn |
| Jun 30, 2020 | 9.01 Mn |
| Dec 31, 2019 | 5.96 Mn |
| Sep 30, 2019 | 7.46 Mn |
| Jun 30, 2019 | 7.86 Mn |
| Mar 31, 2019 | 8.33 Mn |
| Dec 31, 2018 | 2.40 Mn |
| Jun 30, 2018 | 2.85 Mn |
| Dec 31, 2017 | 1.12 Mn |